Epithelial–mesenchymal transition in keloid tissues and TGF‐β1–induced hair follicle outer root sheath keratinocytes
Authors:
- 14 July 2015
- journal article
- Published by Wiley in Wound Repair and Regeneration
- Vol. 23 (4) , 601-610
Abstract
Keloid is a skin fibrotic disease with the characteristics of recurrence and invasion, its pathogenesis still remains unrevealed. The epithelial–mesenchymal transition (EMT) is critical for wound healing, fibrosis, recurrence, and invasion of cancer. We sought to investigate the EMT in keloid and the mechanism through which the EMT regulates keloid formation. In keloid tissues, the expressions of EMT‐associated markers and transforming growth factor (TGF)‐β1/Smad3 signaling were examined by immunohistochemistry. In the keloid epidermis and dermal tissue, the expressions of genes related to the regulation of skin homeostasis, fibroblast growth factor receptor 2 (FGFR2) and p63, were analyzed using quantitative real‐time polymerase chain reaction. The results showed that accompanying the loss of the epithelial marker E‐cadherin and the gain of the mesenchymal markers fibroblast‐specific protein 1 (FSP1) and vimentin in epithelial cells from epidermis and skin appendages, and in endothelial cells from dermal microvessels, enhanced TGF‐β1 expression and Smad3 phosphorylation were noted in keloid tissues. Moreover, alternative splicing of the FGFR2 gene switched the predominantly expressed isoform from FGFR2‐IIIb to ‐IIIc, concomitant with the decreased expression of ΔNp63 and TAp63, which changes might partially account for abnormal epidermis and appendages in keloids. In addition, we found that TGF‐β1‐induced hair follicle outer root sheath keratinocytes (ORSKs) and normal skin epithelial cells underwent EMT in vitro with ORSKs exhibiting more obvious EMT changes and more similar expression profiles for EMT‐associated and skin homeostasis‐related genes as in keloid tissues, suggesting that ORSKs might play crucial roles in the EMT in keloids. Our study provided insights into the molecular mechanisms mediating the EMT pathogenesis of keloids.Keywords
This publication has 39 references indexed in Scilit:
- Downregulation of type I collagen expression in silibinin-treated human skin fibroblasts by blocking the activation of Smad2/3-dependent signaling pathways: Potential therapeutic use in the chemoprevention of keloidsInternational Journal of Molecular Medicine, 2013
- Molecular dissection of abnormal wound healing processes resulting in keloid diseaseWound Repair and Regeneration, 2010
- Epithelial-Mesenchymal Transitions in Development and DiseaseCell, 2009
- Inflammation and EMT: an alliance towards organ fibrosis and cancer progressionEMBO Molecular Medicine, 2009
- Green Tea Polyphenol Epigallocatechin-3-Gallate Suppresses Collagen Production and Proliferation in Keloid Fibroblasts via Inhibition of the STAT3-Signaling PathwayJournal of Investigative Dermatology, 2008
- Gene Profiling of Keloid Fibroblasts Shows Altered Expression in Multiple Fibrosis-Associated PathwaysJournal of Investigative Dermatology, 2008
- Cellular and molecular mechanisms of fibrosisThe Journal of Pathology, 2007
- Keloid-derived fibroblasts show increased secretion of factors involved in collagen turnover and depend on matrix metalloproteinase for migrationBritish Journal of Dermatology, 2005
- Insulin-Like Growth Factor-I Enhances Transforming Growth Factor-β-Induced Extracellular Matrix Protein Production Through the P38/Activating Transcription Factor-2 Signaling Pathway in Keloid FibroblastsJournal of Investigative Dermatology, 2003
- On the Nature of Hypertrophic Scars and Keloids: A ReviewPlastic and Reconstructive Surgery, 1999